Cover Image
市場調查報告書

植入型助聽器、生醫材料的全球市場:佔有率、策略、預測 (2017-2023年)

Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023

出版商 WinterGreen Research, Inc. 商品編碼 540888
出版日期 內容資訊 英文 162 Pages
訂單完成後即時交付
價格
Back to Top
植入型助聽器、生醫材料的全球市場:佔有率、策略、預測 (2017-2023年) Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023
出版日期: 2017年08月09日 內容資訊: 英文 162 Pages
簡介

全球植入型助聽器及相關材料的市場規模,預計2017年達到18億美元,至2023年達到58億美元。

本報告提供全球植入型助聽器、生醫材料市場相關調查,市場概要與市場動態,市場佔有率與市場預測,產品概要,研究、技術,主要企業等系統性資訊。

摘要整理

第1章 植入型助聽器的生醫材料:市場說明、市場動態

  • 人工電子耳的利用
  • 耳朵的說明
  • 兩耳CI配件
  • 人工電子耳的生醫材料
  • 植入型助聽器的生醫材料

第2章 植入型助聽器、生醫材料市場佔有率、預測

  • 植入型助聽器、生醫材料市場促進要素
  • 植入型助聽器市場佔有率
  • 生醫材料市場預測
  • 全球生醫材料市場
  • 人工電子耳 (CI)的技術規格
  • 生醫材料價格
  • 生醫材料的地區區分分析

第3章 生醫材料植入型助聽器的產品說明

  • Cochlear
  • Med-El GmbH的 Flex EAS
  • Sonova / Advanced Bionics AG

第4章 生醫材料研究、技術

  • 醫療設備規格、植入規格:ASTM International
  • 金屬植入
  • 植入型助聽器補綴生醫材料

第5章 人工電子耳生醫材料企業簡介

  • Cochlear
  • Med-EL Maestro
  • Nurotron Biotechnology Co., Ltd. (中國)
  • Sonova / Advanced Bionics AG
  • William Demant / Oticon Medical / Neurelec

WinterGreen的調查

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SH27104999

Hearing Implants and Biomaterial markets are poised to achieve significant growth with increasing use of next generation metals, polymers, and ceramics set to enhance the value of hearing surgery and improve surgical outcomes. By improving hearing of people with profound hearing deficits. Improvements is hearing for severely deaf infants, children and adults particularly old people are dramatic.

Small implant, great results is the norm. The best results were found among children who received the cochlear implant at 0-3 years of age. They achieved 90 to 95 percent hearing and language improvement. 80-90 percent of these children develop a hearing and speech equal to those of children with normal hearing.

Biomaterials inside CI are biological materials that are implanted into the ear area to repair hearing. All CI manufacturers use platinum contacts in electrode production. Iridium oxide coatings have been investigated, which show beneficial effects of impedance.

Biomaterials for hearing implants depend on components, structural polymers, and electrodes. Biomaterials have transformed medical treatment of hearing loss. The ear functioning, hearing loss is able to be addressed with functioning repaired via a device implant that leverages biomaterials.

The cochlear implant has become widely recognized as an established treatment for profound hearing loss. This bodes well for market growth, as there is minimal, less than one percent market penetration now. New materials and greater surgeon experience are expected to reduce the cost of the implant, both the device and the procedure.

Economies of scale always decrease costs and increase market size. The trend likely to continue is for Cochlear implants as medical devices to continue to be used more often. Implants bypass damaged structures in the inner ear and directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.

Cochlear implants are not indicated for all hard of hearing or deaf people. They are not recommended in people who function well with hearing aids.

The implant works by picking up incoming sounds. Incoming sounds are converted to electrical currents and directed to a number of contact points on the internal wire. This operation creates an electrical field which directly stimulates the auditory nerve, thus bypassing the defective inner ear. Cochlear implants convert sound waves to electrical impulses and transmit them to the inner ear, providing people with the ability to hear sounds and potentially better understand speech without reading lips.

According to Susan Eustis, lead author of the team that prepared the study, “Cochlear implants extend the medical device markets by enabling a bypass of damaged structures in the inner ear. They directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.”

The worldwide market for Hearing Implants and associated biomaterials is $1.8 billion in 2017, anticipated to reach $5.8 billion by 2023. The complete report provides a comprehensive analysis of hearing implants in different categories, illustrating the diversity of uses for devices in auditory surgery by age group. A complete procedure analysis is done, looking at numbers of procedures and doing penetration analysis.

Table of Contents

Hearing Implant Biomaterials Executive Summary

  • Hearing Implants Biomaterials Market Driving Forces
    • Surgical Cochlear Implantation Is By And Large Safe
  • Hearing Implant Market Shares
  • Hearing Implant Biomaterials Market Forecasts

1. Biomaterials for Hearing Implants: Market Description and Market Dynamics

  • 1.1. Use Of Cochlear Implants
  • 1.2. Ear Description
    • 1.2.1. Cochlear Implant (CI) System
    • 1.2.2. Biomaterial As A Substance
  • 1.3. Bilateral CI Fitting
  • 1.4. Cochlear Implants Biomaterials
    • 1.4.1. Silicone
    • 1.4.2. Platinum
    • 1.4.3. Titanium
    • 1.4.4. Ceramics
  • 1.5. Biomaterials in Hearing Implant

2. Hearing Implants and Biomaterials Market Shares and Forecasts

  • 2.1. Hearing Implants and Biomaterials Market Driving Forces
    • 2.1.1. Surgical Cochlear Implantation Is By And Large Safe
  • 2.2. Hearing Implant Market Shares
    • 2.2.1. Cochlear
    • 2.2.2. Advanced Bionics AG
    • 2.2.3. Med-EL EAS
  • 2.3. Biomaterials Market Forecasts
    • 2.3.1. Biomaterial Hearing Implant Segments, Children, Adults Age 19 to 50, Adults 51 to 64, Adults Over 65, Market Forecasts
    • 2.3.2. Biomaterial Hearing Implant Market Installed Base Forecasts
  • 2.4. Global Biomaterials Market
    • 2.4.1. Optimizing the Biocompatibility Properties Of The Hearing Implant
    • 2.4.2. Biofilms
    • 2.4.3. Teflon for Cochlear Implants
    • 2.4.4. Electrically Conducting Polymers
    • 2.4.5. Polyimides
    • 2.4.6. Silicon Electrodes
    • 2.4.7. Physical Functionalization Of Surfaces
    • 2.4.8. Drug Delivery In The Inner Ear (Neurotrophic Effects)
    • 2.4.9. BioMaterial Nanoparticles
    • 2.4.10. Nanoparticles And Cochlear Implants
    • 2.4.11. Biomaterials Market Overview
  • 2.5. Cochlear (CI) Implant Technical Specifications
    • 2.5.1. Advanced Bionics Technical Specifications
    • 2.5.2. Cochlear Technical Specifications
  • 2.6. Biomaterials Pricing
  • 2.7. Biomaterials Regional Segment Analysis
    • 2.7.1. United States
    • 2.7.2. Europe
    • 2.7.3. Rapid Development of Middle Class in South America

3. Biomaterial Hearing Implants Product Description

  • 3.1. Cochlear
    • 3.1.1. Cochlear Kanso™ Sound Processor
    • 3.1.2. Cochlear Nucleus® 6 Sound Processor
    • 3.1.3. Cochlear Hearing Implant Specifications
    • 3.1.4. Cochlear Implant Technical Specifications
  • 3.2. Med-El GmbH's Flex EAS
    • 3.2.1. Med-EL EAS™ Hearing Implant System for Partial Mild To Moderate Deafness
    • 3.2.2. Hearing Implant Advantages Of Bilateral Implantation
    • 3.2.3. MedEL Implant Concerto
    • 3.2.4. MedEL Implant Concerto Structure Preservation
    • 3.2.1. MedEL Implant Concerto Complete Cochlear Coverage CCC
    • 3.2.2. Med-EL Electrode Arrays
    • 3.2.3. Med-EL FLEX Tip Technology
    • 3.2.4. Med-EL Classic Series
    • 3.2.5. Med-EL FLEX Series
    • 3.2.6. FDA Approves the MED-EL Synchrony EAS Hearing Implant System
    • 3.2.7. Med-EL Addresses Hearing Loss in the US
    • 3.2.8. MED-EL Technical Specifications
  • 3.3. Sonova / Advanced Bionics AG
    • 3.3.1. Advanced Bionics Implant Specifications

4. Biomaterials Research and Technology

  • 4.1. Medical Device Standards and Implant Standards - ASTM International
  • 4.2. Metalic Implants
    • 4.2.1. Unalloyed Titanium
    • 4.2.2. Titanium Alloy
  • 4.3. Hearing Implant Prosthesis Biomaterials

5. Ear Implant Biomaterials Company Profiles

  • 5.1. Cochlear
    • 5.1.1. Cochlear Revenue
  • 5.2. Med-EL Maestro
    • 5.2.1. Med-EL Hearing Implant Concerto
    • 5.2.2. Med-EL Revenue
    • 5.2.3. Med-EL Implantable Solutions
  • 5.3. Nurotron Biotechnology Co., Ltd. (China)
    • 5.3.1. Nurotron Biomaterials Positioning
    • 5.3.2. Nurotron Biotechnology Thin, Ergonomic, Titanium Implant Package
    • 5.3.3. Nurotron Biotechnology Expands Facilities, Staff Ten-Fold
    • 5.3.4. Nurotron Biotechnology Co., Ltd. (nurotron.com)
  • 5.4. Sonova / Advanced Bionics AG
    • 5.4.1. Sonova Group Revenue / Advanced Bionics
    • 5.4.2. Sonova / Advanced Bionics
  • 5.5. William Demant / Oticon Medical / Neurelec

WinterGreen Research,

  • WinterGreen Research Methodology

List of Figures

  • Figure 1. Hearing Implant Market Leaders Worldwide
  • Figure 2. Biomaterial Hearing Implant Market, Shares, Dollars, Worldwide, 2016
  • Figure 3. Biomaterial Hearing Implant Market Shares, Dollars, Worldwide, 2016
  • Figure 4. Hearing Implants Market Forecasts, Dollars, Worldwide, 2017-2023
  • Figure 5. Cochlear Implant
  • Figure 6. Implantable Portion Of The Cochlear Implant:
  • Figure 7. Components of the Ear
  • Figure 8. Biomaterials Clinical Disciplines Underpin The Design
  • Figure 9. Biomaterials Sciences
  • Figure 10. Biomaterials Uses in Clinical Diagnosis And Therapy
  • Figure 11. Biomaterials in Hearing Implant
  • Figure 12. Biomaterials for Receiver
  • Figure 13. Electrode Array Biomaterials
  • Figure 14. Electrode Contacts Biomaterials Requirement
  • Figure 15. Cocolear Implant CI Biocompatibilty Issues
  • Figure 16. Hearing Implant Market Leaders Worldwide
  • Figure 17. Biomaterial Hearing Implant Market Shares, Dollars, Worldwide, 2016
  • Figure 18. Biomaterial Hearing Implant Market Shares, Dollars, Worldwide, 2016
  • Figure 19. Hearing Loss Implant Reliability of Leading Three Vendors
  • Figure 20. Advanced Bionics Cochlear Implant
  • Figure 21. Hearing Implants Market Forecasts, Dollars, Worldwide, 2017-2023
  • Figure 22. Biomaterials Hearing Implant Market Forecasts, Units, Worldwide, 2017-2023
  • Figure 23. Biomaterial Hearing Implant Market Forecasts, Dollars and Units, Worldwide, 2017-2023
  • Figure 24. Hearing Loss Market Metrics
  • Figure 25. Biomaterial Hearing Implant Segments, Children, Adults Age 19 to Adults 51 to 64, Adults Over 65, Market Forecasts Dollars, Worldwide, 2017-2023
  • Figure 26. Biomaterial Hearing Implant Segments, Children, Adults Age 19 to Adults 51 to 64, Adults Over 65, Market Forecasts, Percent, Worldwide, 2017-2023 57
  • Figure 27. Biomaterial Hearing Implant Market Installed Base Forecasts, Units, Worldwide, 2017-2023
  • Figure 28. Biomaterial Hearing Implant Market Penetration Forecasts, Units, Worldwide, 2017-2023
  • Figure 29. Application Segments Of Biomaterials
  • Figure 30. Surface Structuring Physical Functionalization Aspects
  • Figure 31. Major Players In The Global Biomaterials Market
  • Figure 32. Hyaluronic Acid-based Biomaterials Manufacturers
  • Figure 33. Biomaterials Market, by Type of Material
  • Figure 34. Biomaterials Market, by Application
  • Figure 35. Cochlear Technical Specifications
  • Figure 36. Biomaterial Hearing Implant Regional Market Segments, Dollars, Worldwide, 2016
  • Figure 37. Hearing Implant and Biomaterials Regional Market Segments, Dollars, 2016 81
  • Figure 38. United States Hearing Implant Market Growth Drivers
  • Figure 39. United States Hearing Implant Nanotechnology Growth Drivers
  • Figure 40. Rapid Development of Middle Class in South America
  • Figure 41. SIze of the Middle Class in Latin America
  • Figure 42. Severe to Profound Hearing Loss in Latin America
  • Figure 43. CI Penetration in Latin America
  • Figure 44. Cochlear Staff in Latin America
  • Figure 45. Cochlear Expanding Reimbursement in Latin America
  • Figure 46. Cochlear Nucleus System
  • Figure 47. Cochlear Implant Functions
  • Figure 48. Cochlear Implant Hearing Improvement in Noisy Environments
  • Figure 49. Cochlear Kanso™ Sound Processor
  • Figure 50. Cochlear Nucleus® 6 Sound Processor
  • Figure 51. Cochlear Hearing Implant Functions
  • Figure 52. Cochlear Advantages Of Perimodiolar Electrodes
  • Figure 53. Cochlear Slim Modular Electrode
  • Figure 54. Cochlear Slim Modiolar Electrode Hearing Outcomes For Patients
  • Figure 55. Cochlear Electrode Placement
  • Figure 56. Cochlear Implant Technical Specifications
  • Figure 57. Med-EL Hearing Implant
  • Figure 58. MedEL MAESTRO Cochlear Implant System
  • Figure 59. MedEL MAESTRO consists of both an internal cochlear implant and an externally worn audio processor.
  • Figure 60. MedEL Implant Concerto
  • Figure 61. Med-EL Biomaterial Electrodes Features
  • Figure 62. Med-EL ASM Key Features
  • Figure 63. Med-EL FLEX Tip Technology Features
  • Figure 64. Med-EL Hearing Implant Electrode Array Featuring FLEX-Tip Technology
  • Figure 65. Med-EL Synchrony EAS Hearing Implant
  • Figure 66. MED-EL Technical Specifications Implant
  • Figure 67. Advanced Bionics Cochlear Implant
  • Figure 68. Advanced Bionics Technical Specifications
  • Figure 69. Cochlear Electrode Type Comparison
  • Figure 70. Cochlear Slim Straight Electrode
  • Figure 71. Cochlear Regional Presence in Americas and Europe
  • Figure 72. Cochlear Nucleus Implant Installed Base
  • Figure 73. Cochlear Regional Presence in Asia Pacific
  • Figure 74. Cochlear Leadership Position in Implantable Hearing Devices
  • Figure 75. Hearing Loss Market Opportunity Metrics
  • Figure 76. Cochlear Biomaterials Core Technology Positioning
  • Figure 77. Cochlear Positioning for Developing Growth Markets
  • Figure 78. Cochlear Growth of Services Revenue
  • Figure 79. Cochlear FY 2017 Financial Outlook
  • Figure 80. Cochlear Implant Market Awareness Opportunity
  • Figure 81. Cochlear Implant Services Revenue Components
  • Figure 82. Cochlear Slim Modiolar Electrode Array Image
  • Figure 83. Cochlear Nucleus Profile with Slim Modiolar Electrode Array - C1532
  • Figure 84. Cochlear Electrode Type Comparison
  • Figure 85. Cochlear Hearing Loss Implant Criteria for Electrode Choice
  • Figure 86. Med-EL Hearing Implant CONCERTO
  • Figure 87. Nurotron Biotechnology Venus Cochlear Implant System
  • Figure 88. Nurotron Biomaterials Positioning
Back to Top